CEACAMP4

Across TCGA pan-cancer cohorts, CEACAMP4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CEACAMP4 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CEACAMP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CEACAMP4 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

HNSC, MESO, and UCEC are the cancer types where CEACAMP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.235	0.616	<.001	72	view →
MESO	OS	Tertile	II,III,IV	0.121	0.571	.004	54	view →
UCEC	DFS	Tertile	All	0.781	0.902	.004	36	view →
THCA	OS	Tertile	All	0.320	0.957	<.001	30	view →
BRCA	OS	Tertile	III,IV	0.106	0.548	.005	30	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	28	view →
SKCM	OS	Tertile	II,III,IV	0.258	0.738	.003	27	view →
CHOL	OS	Tertile	All	0.296	0.673	.023	24	view →
PAAD	OS	Tertile	II,III,IV	0.285	0.560	.024	18	view →
LUAD	OS	Tertile	III,IV	0.158	0.660	.019	18	view →
READ	DFS	Tertile	II,III,IV	0.391	0.823	.014	9	view →
ACC	OS	Tertile	III,IV	0.357	0.751	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

CEACAMP4–HNSC (OS)

Open the HNSC breakdown →